Home Cart Sign in  
Chemical Structure| 475479-34-6 Chemical Structure| 475479-34-6

Structure of Aleglitazar
CAS No.: 475479-34-6

Chemical Structure| 475479-34-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aleglitazar is a dual PPAR-α/γ agonist with IC50 of 2.8 nM/4.6 nM.

Synonyms: RO0728804; R1439; RG-1439

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Aleglitazar

CAS No. :475479-34-6
Formula : C24H23NO5S
M.W : 437.51
SMILES Code : CC1=C(CCOC2=CC=C(C[C@@H](C(O)=O)OC)C3=C2C=CS3)N=C(C4=CC=CC=C4)O1
Synonyms :
RO0728804; R1439; RG-1439
MDL No. :MFCD09954107

Safety of Aleglitazar

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01615354 Healthy Volunteer Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M13 9WL Less <<
NCT00388518 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00461058 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT01398267 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Nebraska Omaha, Nebraska, United States, 68154 United States, Texas Dallas, Texas, United States, 75247 San Antonio, Texas, United States, 78209 Less <<
NCT00461006 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT01729403 Diabetes Mellitus Type 2 Phase 2 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01691989 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01680978 Diabetes Mellitus Type 2 Phase 2 Completed - United Kingdom ... More >> Oxford, United Kingdom, OX3 9DU Less <<
NCT01188317 Healthy Volunteer Phase 1 Completed - United States, Nebraska ... More >> Omaha, Nebraska, United States, 68154 Less <<
NCT01893242 Diabetes Mellitus Type 2, Kidn... More >>ey Disease, Chronic Less << Phase 3 Withdrawn January 2019 -
NCT01042769 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01691846 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01871415 Diabetes Mellitus Type 2 Phase 3 Completed - China ... More >> Shanghai, China, 200003 ShenYang, China, 110004 Shiyan, China, 442000 Suzhou, China, 215004 Korea, Republic of Gyeonggi-do, Korea, Republic of, 463-712 Incheon, Korea, Republic of, 405-760 Seoul, Korea, Republic of, 150-950 Less <<
NCT01188304 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78209 Less <<
NCT01715818 Cardiovascular Disease, Diabet... More >>es Mellitus Type 2 Less << Phase 3 Completed - -
NCT01871428 Diabetes Mellitus Type 2 Phase 3 Completed - China ... More >> Chongqing, China, 400016 Shanghai, China, 200003 Shiyan, China, 442000 Suzhou, China, 215004 Hong Kong Hong Kong, Hong Kong Malaysia Alor Setar, Malaysia, 05400 Perak, Malaysia, 33400 Less <<
NCT01711775 Healthy Volunteer Phase 1 Completed - China ... More >> Beijing, China, 100083 Less <<
NCT01691755 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01679639 Healthy Volunteer Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M13 9WL Less <<
NCT01701739 Healthy Volunteer Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M13 9WL Less <<
NCT01197911 - Completed - -
NCT01197911 Healthy Volunteer Phase 1 Completed - United States, Florida ... More >> Orlando, Florida, United States, 32809 United States, Tennessee Knoxville, Tennessee, United States, 37920 Less <<
NCT01043029 Diabetes Mellitus Type 2 Phase 2 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.29mL

0.46mL

0.23mL

11.43mL

2.29mL

1.14mL

22.86mL

4.57mL

2.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories